Mitochondrial aspartate/glutamate carrier SLC25A12 gene is associated with autism.

Autism Res

Department of Molecular Medicine and Institute for Molecular Medicine, Finland, National Public Health Institute, Helsinki, Finland.

Published: June 2008

Two single nucleotide polymorphisms (SNP) within Mitochondrial Aspartate/Glutamate Carrier SLC25A12 gene have recently shown to be strongly associated with autism. Here, we attempted to replicate this finding in two separate Finnish samples with autism spectrum disorders. Family-based association analysis of two SNPs, rs2056202 and rs2292813, previously shown to be associated with autism was performed in two samples with different phenotypic characteristics. The samples included 97 families with strictly defined autism and 29 extended families with Asperger syndrome (AS). We detected association at rs2292813 (FBAT, P=0.0018) in the Finnish autism sample. In, addition other family-based analysis methods supported this finding. By contrast, analysis of the AS sample yielded no evidence for association. This study shows further support that genetic variants within SLC25A12 gene contribute to the etiology of autism.

Download full-text PDF

Source
http://dx.doi.org/10.1002/aur.25DOI Listing

Publication Analysis

Top Keywords

slc25a12 gene
12
associated autism
12
mitochondrial aspartate/glutamate
8
aspartate/glutamate carrier
8
carrier slc25a12
8
gene associated
8
autism
7
autism single
4
single nucleotide
4
nucleotide polymorphisms
4

Similar Publications

OXPHOS mediators in acute myeloid leukemia patients: Prognostic biomarkers and therapeutic targets for personalized medicine.

World J Surg Oncol

November 2024

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo, 11566, Egypt.

Background: Despite significant advances in comprehending its tumorigenic role, the prognostic and therapeutic potential of targeting oxidative phosphorylation (OXPHOS) in acute myeloid leukemia (AML) remain obscure.

Methods: The prognostic value of ~ 200 mitochondrial/OXPHOS genes as candidate biomarkers was examined in AML patients over ~ 10 years follow-up using Kaplan-Meier and Cox regression analyses. Furthermore, the transcript levels of the assessed markers were inspected in healthy bone marrow tissues and the dependencies of AML cells on the assessed genes were examined.

View Article and Find Full Text PDF

Objective: To explore the genetic basis for a child featuring global developmental delay and epilepsy.

Methods: A child who had presented at Guangzhou Women and Children's Medical Center Liuzhou Hospital on February 19, 2023 was selected as the study subject. Clinical data of the child was collected.

View Article and Find Full Text PDF

Aspartate-glutamate carrier isoform 1 (AGC1) is a carrier responsible for the export of mitochondrial aspartate in exchange for cytosolic glutamate and is part of the malate-aspartate shuttle, essential for the balance of reducing equivalents in the cells. In the brain, mutations in SLC25A12 gene, encoding for AGC1, cause an ultra-rare genetic disease, reported as a neurodevelopmental encephalopathy, whose symptoms include global hypomyelination, arrested psychomotor development, hypotonia and seizures. Among the biological components most affected by AGC1 deficiency are oligodendrocytes, glial cells responsible for myelination processes, and their precursors [oligodendrocyte progenitor cells (OPCs)].

View Article and Find Full Text PDF

Background: Diabetic foot ulcer (DFU) is one of the most common and severe complications of diabetes, with vascular changes, neuropathy, and infections being the primary pathological mechanisms. Glutamine (Gln) metabolism has been found to play a crucial role in diabetes complications. This study aims to identify and validate potential Gln metabolism biomarkers associated with DFU through bioinformatics and machine learning analysis.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of calcium signaling in autism spectrum disorder (ASD) by comparing gene expressions in blood samples from ASD patients and healthy children.
  • Findings show that SLC1A1 expression is significantly lower, while LINC01231 and RYR2 are notably higher in ASD cases, suggesting these genes might be linked to the disorder.
  • The study's results indicate potential diagnostic value for these genes, laying groundwork for further research into their roles in neurodevelopmental issues like ASD.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!